Forbes: This New York City Pharma Startup Wants To Turn LSD Into An FDA-Approved Medicine For Anxiety Disorder

This New York City Pharma Startup Wants To Turn LSD Into An FDA-Approved Medicine For Anxiety Disorde

Will Yakowicz Forbes Staff

jr rahn of mind medicine shark tank kevin o'leary
Mind Medicine Inc. cofounder JR Rahn with "Shark Tank" star and investor Kevin O'Leary. COURTESY OF MIND MEDICINE INC./SPENCER XIONG PHOTOGRAPHY

Mind Medicine Inc., a New York-based psychedelic drug development company, that counts Shark Tank star Kevin O’Leary and Toms Shoes founder Blake Mycoskie as investors, has acquired the exclusive rights to eight clinical trials that are exploring the medicinal properties of the powerful hallucinogen lysergic acid diethylamide (LSD). One of the studies is an ongoing, placebo-controlled Phase 2 trial of LSD for the treatment of anxiety disorder.

https://www.forbes.com/sites/willyakowicz/2020/04/01/this-new-york-city-pharma-startup-wants-to-turn-lsd-into-an-fda-approved-medicine-for-anxiety-disorder/#754c87713293